ClinicalTrials.gg
CompletedNCT05618262Renal-ColicUpdated Dec 15, 2023

Evaluation of the Emergency Imaging Strategy for the Diagnostic Management of Renal Colic

An observational study in Renal Colic, sponsored by University Hospital, Strasbourg, France. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-15.

Sponsored by University Hospital, Strasbourg, France · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
169
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 12 studies in Renal Colic with a site in France — none open to participants now, none under way, none of them phase 3. Renal Colic · France.

Started
2020
with 1 other
Observational
4 of 12
none open now
Registered
11th of 12
by date
Lead sponsor
1 of 12
University Hospital, Strasbourg, France

Among the 12 studies in Renal Colic with a site in France, this one is one of 2 that started in 2020, is one of 4 observational ones, and was the 11th registered.

By phase

12 studies; the count open now beside each. This study's row is marked.

No phase6 · 0 open
Observationalthis study4 · 0 open
Phase 21 · 0 open
Phase 41 · 0 open

By the year they started

First in 2013; this study’s year is marked. 2 started in 2020.

What they test

Size and results

Median enrollment 95 across the 8 interventional studies, 115 across the 4 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Download CSVWith an account: the 12 studies in Renal Colic with a site in France as a file.
02

Study summary

Emergency imaging is necessary for the diagnostic management of renal colic in the emergency department. Ultrasound is rapidly available and non-irradiating, allowing to look for a stone and a pyelocalic dilatation. But it is less sensitive when the stone is ureteral. CT has a sensitivity of 96% and a specificity of 100%. The latest French recommendations date from 2008, recommending ultrasound and an unprepared abdomen in cases of uncomplicated renal colic. For the European Society of Radiology, ultrasound should be the first-line examination. The place of a systematic CT scan as first-line examination for the diagnosis of renal colic in the emergency department is therefore still under discussion.

An evaluation of practice will make it possible to assess the imaging strategy applied in an emergency department.

03

Conditions studied

  • Renal Colic

Browse trials for

Keywords

  • Renal Colic
  • Nephritic Colic
  • Pyelocalic dilatation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Major subject (≥18 years) who was managed in the NHC emergency department from July 01, 2018 to June 30, 2019 with a final diagnosis of renal colic diagnostic

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Major subject (≥18 years)
  • Subject who was managed in the NHC emergency department from July 01, 2018 to June 30, 2019 with a final diagnosis of renal colic diagnostic
  • Subject who has not expressed opposition, after information, to the reuse of their data for the purpose of this research

Exclusion criteria

Exclusion criteria:

  • Subject who has expressed opposition to participating in the study
  • Subject under guardianship or curatorship
  • Subject under legal protection
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
169 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Retrospective study of the practices of management of renal colic in the emergency room concerning the imaging strategy

    Time frame: Files analysed retrospectively from from July 01, 2018 to June 30, 2019 will be examined

07

Study locations

1 site
  • Service d'accueil des urgences - CHU de Strasbourg - France
    Strasbourg, 67091, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2020 to primary completion in May 2020, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2022
First posted
Nov 16, 2022
StartActual
Jan 14, 2020
Primary completionActual
May 14, 2020
CompletionActual
May 14, 2020
Last update
Dec 15, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05618262
Responsible party
Sponsor
First posted
Nov 16, 2022
Start date
Jan 14, 2020
Primary completion
May 14, 2020
Completion
May 14, 2020
Last update
Dec 15, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion